• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Immunovant, Inc. - Common Stock (NQ:IMVT)

    34.78 +0.65 (+1.90%)
    Streaming Delayed Price Updated: 1:52 PM EDT, May 22, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Immunovant, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 Next >
    News headline image
    40 Stocks Moving In Monday's Mid-Day Session ↗
    Gainers Ever-Glory International Group, Inc. (NASDAQ: EVK) shares jumped 133% to $5.27 after the company announced a $5 million stock repurchase program. Exicure, Inc. (NASDAQ:... 
    Via Benzinga
    News headline image
    Mid-Morning Market Update: Markets Open Higher; Global Payments Posts Upbeat Q2 Earnings ↗
    Following the market opening Monday, the Dow traded up 0.58% to 35,138.90 while the NASDAQ rose 0.40% to 14,731.03. The S&P also rose, gaining 0.46% to 4,415.36. The U.S. has... 
    Via Benzinga
    Topics Stocks
    News headline image
    Stocks That Hit 52-Week Lows On Monday ↗
    Monday morning, 34 companies reached new 52-week lows. Things to Consider: Las Vegas Sands (NYSE:LVS) was the largest, in terms of market cap, to set a new 52-week... 
    Via Benzinga
    News headline image
    Immunovant Stock Plunges On $200M Equity Investment From Roivant To Support IMVT-1401 Development ↗
    Immunovant Inc (NASDAQ: IMVT) has received a $200 million strategic investment from Roivant Sciences that the Company will use to advance IMVT-1401 in... 
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
    Gainers Exicure (NASDAQ:XCUR) stock moved upwards by 35.55% to $1.83 during Monday's pre-market session. The company's market cap stands at $161.0 million.... 
    Via Benzinga
    News headline image
    Biotech Losers In 2021 That Could Bounce Big In The Second Half ↗
    Biotech stocks are tricky investment bets that require careful analysis and scrutiny. Here's a list of biotech stocks that were among the worst performers in the first half but have the potential to... 
    Via Talk Markets
    News headline image
    Biotech Losers In 2021 That Could Bounce Big In The Second Half ↗
    Biotech stocks are tricky investment bets that require careful analysis and scrutiny. A stock that has fallen off a cliff in reaction to a binary event can neither be written off... 
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Thursday's Intraday Session ↗
    Gainers Kindred Biosciences (NASDAQ:KIN) shares increased by 24.08% to $6.75 during Thursday's regular session. Kindred Biosciences's stock is trading at a volume... 
    Via Benzinga
    News headline image
    The Daily Biotech Pulse: FDA Nod For Novartis, iRhythm CEO Quits Abruptly, Moderna Inks Vaccine Supply Agreements ↗
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 1) Anika Therapeutics, Inc. (... 
    Via Benzinga
    News headline image
    10 Biggest Price Target Changes For Wednesday ↗
    Citigroup cut the price target for AutoZone, Inc. (NYSE: AZO) from $1,700 to $1,636. AutoZone shares rose 0.3% to close at $1,410.85 on Tuesday. Barclays raised the price target... 
    Via Benzinga
    News headline image
    Mid-Afternoon Market Update: Dow Rises 90 Points; Cloudera Shares Spike Higher ↗
    Toward the end of trading Tuesday, the Dow traded up 0.26% to 34,620 while the NASDAQ rose 0.13% to 13,766.75. The S&P also rose, gaining 0.09% to 4,207.71. The U.S... 
    Via Benzinga
    Topics Stocks
    News headline image
    68 Biggest Movers From Yesterday ↗
    Gainers Orbital Energy Group, Inc. (NASDAQ: OEG) shares surged 115.2% to close at $7.64 on Tuesday after the company announced its subsidiary, Gibson Technical Services, reached... 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
    Gainers Nuwellis (NASDAQ:NUWE) stock incr... 
    Via Benzinga
    News headline image
    Mid-Day Market Update: Crude Oil Surges 3.5%; Immunovant Shares Plummet ↗
    Midway through trading Tuesday, the Dow traded up 0.35% to 34,651.75 while the NASDAQ fell 0.31% to 13,705.51. The S&P also rose, gaining 0.04% to 4,205.97. The U.S. has the... 
    Via Benzinga
    Topics Stocks
    News headline image
    36 Stocks Moving In Tuesday's Mid-Day Session ↗
    Gainers Orbital Energy Group, Inc. (NASDAQ: OEG) shares jumped 67.3% to $5.94 after the company announced its subsidiary, Gibson Technical Services, reached an agreement with TEC... 
    Via Benzinga
    News headline image
    Mid-Morning Market Update: Markets Mixed; ISM Manufacturing PMI Rises to 61.2 In May ↗
    Following the market opening Tuesday, the Dow traded up 0.28% to 34,625.27 while the NASDAQ fell 0.23% to 13,717.52. The S&P also rose, gaining 0.06% to 4,206.76. The U.S. has... 
    Via Benzinga
    Topics Stocks
    News headline image
    Stocks That Hit 52-Week Lows On Tuesday ↗
    Before 10 a.m. ET on Tuesday, 4 companies set new 52-week lows. Intriguing Points: Immunovant (NASDAQ:IMVT) was the largest firm by market cap to set a new 52-week... 
    Via Benzinga
    News headline image
    NASDAQ:IMVT Long Term Shareholder Notice: Investigation over Possible Wrongdoing at Immunovant, Inc. ↗
    San Diego, CA -- (SBWIRE) -- 05/19/2021 -- An investigation was announced concerning potential breaches of fiduciary duties by certain directors of Immunovant, Inc. 
    Via SBWire
    Topics Lawsuit
    News headline image
    'SPACs Attack' Recap: Looking Back At 5 SPAC Deals, Rumors And Top Headlines ↗
    Last week featured five announced SPAC deals and several rumors. The week also had earnings from several well-known former SPACs. Here is a look back at the week in SPACs for... 
    Via Benzinga
    News headline image
    Roivant Sciences Gets SPAC Deal: What To Expect From This BioPharma, Health Technology Company ↗
    A drug discovery company with ownership stakes in several public and private biopharmaceutical companies is going public with a SPAC deal announced Monday morning. The SPAC Deal:... 
    Via Benzinga
    News headline image
    DEADLINE TOMORROW: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Immunovant, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Lawsuit
    News headline image
    TUESDAY DEADLINE NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Immunovant, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Lawsuit
    News headline image
    TUESDAY DEADLINE REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Immunovant, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Lawsuit
    News headline image
    The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation (IMVT)
    From The Law Offices of Frank R. Cruz
    Via Business Wire
    News headline image
    TUESDAY DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Immunovant, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Lawsuit
    News headline image
    7-DAY DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Immunovant, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Lawsuit
    News headline image
    UPCOMING DEADLINE NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Immunovant, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Lawsuit
    News headline image
    NASDAQ:IMVT Investor Notice: Deadline on April 20, 2021 in Lawsuit Against Immunovant, Inc. ↗
    San Diego, CA -- (SBWIRE) -- 04/07/2021 -- A deadline is coming up on April 20, 2021 in the lawsuit filed for certain investors of Immunovant, Inc. (NASDAQ:IMVT). 
    Via SBWire
    Topics Lawsuit
    News headline image
    UPCOMING DEADLINE REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Immunovant, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Lawsuit
    < Previous 1 2 3 4 5 6 7 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.